Sort
21,281 grants matching “influenza”
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$2,203,488John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,202,898Stephen C Harrison · Boston Children'S Hospital · P01 · FY2011 · AI
Systems Approach to Immunity and Inflammation
$2,201,411Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2021 · AI
Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro
$2,200,798Mark M Davis · Stanford University · U19 · FY2025 · AI
Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro
$2,200,798Mark M Davis · Stanford University · U19 · FY2024 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific
$2,200,000Benjamin John Cowling · University Of Hong Kong · U01 · FY2018 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$2,200,000Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2017 · IP
The Infectious Diseases Clinical Research Program
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
$2,198,288Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
A deep longitudinal analysis of next generation influenza vaccines in older adults
$2,195,905Duygu Ucar · Jackson Laboratory · U01 · FY2023 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,194,909Arlene H Sharpe · Harvard Medical School · P01 · FY2014 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$2,193,828Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2020 · IP
Establishment of a Bat Resource for Infectious Disease Research
$2,193,256William A Schountz · Colorado State University · U24 · FY2025 · AI
Integrative analysis and modeling of human immune responses and pathologies
$2,192,745John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Volume of Contamination and Nosocomial Infection Control
$2,191,922Eli N Perencevich · University Of Iowa · U54 · FY2015 · CK
NMR Investigations Of Cell Membrane Structure
$2,190,492Klaus Gawrisch · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$2,190,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2018 · IP
Oklahoma Center for Respiratory and Infectious Diseases
$2,188,662Lin Liu · Oklahoma State University Stillwater · P20 · FY2014 · GM
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$2,185,305Brian Murphy · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Oklahoma Center for Respiratory and Infectious Diseases
$2,185,103Lin Liu · Oklahoma State University Stillwater · P20 · FY2015 · GM
Minnesota Center of Excellence for Influenza Research and Surveillance
$2,182,359Michael T. Osterholm · University Of Minnesota · N01 · FY2009 · AI
Oklahoma Center for Respiratory and Infectious Diseases
$2,181,997Lin Liu · Oklahoma State University Stillwater · P20 · FY2016 · GM
Epicenters for the Prevention of Healthcare Associated Infections (HAI) - Cycle II
$2,181,088Anthony D Harris · University Of Maryland Baltimore · U54 · FY2015 · CK